Medical tech company Masimo (NASDAQ:MASI) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales ...
Jared Holz, Mizuho Securities Healthcare Equity Strategist, says he wouldn't be surprised to see one more bid from Pfizer. He ...